BACKGROUND
Primary debulking surgery before initiation of chemotherapy has been the standard of care for patients with advanced ovarian cancer.
METHODS
We randomly assigned patients with stage IIIC… (More)
PURPOSE
The third-generation nonsteroidal aromatase inhibitors (AIs) are increasingly used as adjuvant and first-line advanced therapy for postmenopausal, hormone receptor-positive (HR+) breast… (More)
Background:Recently, a Risk of Ovarian Malignancy Algorithm (ROMA) utilising human epididymis secretory protein 4 (HE4) and CA125 successfully classified patients as presenting a high or low risk for… (More)
The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy & Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on… (More)
UNLABELLED
Recently, there has been an increasing interest in the development and characterization of patient-derived tumor xenograft (PDX) models for cancer research. PDX models mostly retain the… (More)
PURPOSE
The aim of this study was to assess the management and the obstetrical and neonatal outcomes of pregnancies complicated by cancer.
PATIENTS AND METHODS
In an international collaborative… (More)
PURPOSE
To uncover the neural substrate of cognitive impairment related to adjuvant chemotherapy, we studied cerebral white matter (WM) integrity before and after chemotherapy by using magnetic… (More)
BACKGROUND
Little is known about the treatment of breast cancer during pregnancy. We aimed to determine whether treatment for breast cancer during pregnancy is safe for both mother and child.
… (More)